NIH Director says J&J blood clotting issue a 'truly a rare event'
The director of the National Institutes for Health (NIH) said Sunday that the risk of a serious blood clotting issue posed by the Johnson & Johnson COVID-19 vaccine was truly rare, and disagreed with calls from some f…
Source: TEST FEED1
